Rogério Lilenbaum
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology
Most-Cited Works
- → Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer(2006)5,762 cited
- → NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016(2016)735 cited
- → Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial(2020)530 cited
- → Non–Small Cell Lung Cancer, Version 6.2015(2015)487 cited
- → NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018(2018)467 cited
- → Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730)(2004)451 cited
- → American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes(2014)431 cited
- → Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study(2013)361 cited
- → Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non–Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2(2013)237 cited
- → Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research(2008)218 cited